Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 9 news outlets

twitter: 6 X users

Readers on

mendeley: 10 Mendeley

Summary News X

So far, Altmetric has seen 10 X posts from 6 X users, with an upper bound of 37,210 followers.

RT @AlphaTauMedical: A new study published recently in Frontiers in Oncology shows that each of the #chemotherapy Temozolomide and Avastin,…

07 Dec 2022

Reply Repost Favourite

RT @AlphaTauMedical: A new study published recently in Frontiers in Oncology shows that each of the #chemotherapy Temozolomide and Avastin,…

07 Dec 2022

Reply Repost Favourite

A new study published recently in Frontiers in Oncology shows that each of the #chemotherapy Temozolomide and Avastin, both had augmented effect when combined with the #AlphaDaRT treatment in human #GBM xenografts in mice. To read the full study: https://

06 Dec 2022

Reply Repost Favourite

RT @radonclibrary: Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multifo…

16 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.